Article
Chemoresistant colorectal cancer cells, the cancer stem cell phenotype, and increased sensitivity to insulin-like growth factor-I receptor inhibition.
Cancer research - 1 Mar 2009
Dallas Nikolaos A, Xia Ling, Fan Fan, Gray Michael J, Gaur Puja, van Buren George, Samuel Shaija, Kim Michael P, Lim Sherry J, Ellis Lee M
Abstract excerpt
5-Fluorouracil (5FU) and oxaliplatin are standard therapy for metastatic colorectal cancer (CRC), but the development of chemoresistance is inevitable. Because cancer stem cells (CSC) are hypothesized to be chemoresistant, we investigated CSC properties in newly developed chemoresistant CRC cell lines and sought to identify targets for therapy. The human CRC cell line HT29 was exposed to increasing doses of 5FU...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
